Bionote USA Launches the Vcheck C10, Giving Veterinarians Access to Four Testing Capabilities in a Single Chemistry Analyzer

Revolutionizing Point-of-Care Diagnostics for Veterinarians

BIG LAKE, MINN. (July 20, 2026) – Bionote USA is proud to announce the launch of the Vcheck C10. This versatile chemistry analyzer will revolutionize point-of-care chemistry analysis for veterinarians.

The Vcheck C10 veterinary diagnostic platform is designed to streamline in-clinic testing through a single, expandable system. Built around a central brain capable of running chemistry, urine chemistry, and electrolyte testing, the Vcheck C10 gives veterinary practices the flexibility to customize their diagnostic workflow with up to three add-on modules. This modular design enables simultaneous panel testing and quantitative immunoassay analysis, helping clinics expand testing capabilities while improving efficiency at the point of care.

“The launch of the Vcheck C10 marks an exciting step forward for veterinary diagnostics,” said Bionote CEO Ryan Kim. “Veterinary teams need flexible, efficient solutions that help them make confident decisions quickly, and the C10 was designed with that need in mind. With the innovations in the Vcheck C10, we are giving the veterinary industry a smarter way to streamline in-clinic testing and expand diagnostic possibilities at the point of care.”

The Vcheck C10 reflects Bionote USA’s continued focus on developing diagnostic solutions that meet the evolving needs of modern veterinary practices. By supporting faster, more informed decisions at the point of care, the system helps veterinary teams strengthen workflows and improve the patient experience. The Vcheck C10 is now available through Bionote USA and its authorized distribution partners.

For more information on the Vcheck C10, visit www.bionote.com/vcheck-c10.

Download Press Release